CHEK2 and breast cancer: In order to characterize BC that develop in the setting of germline CHEK2 variants, we explored the clinicopathologic, histologic, and genetic features of BCs arising in a consecutive series of patients with pathogenic or likely pathogenic germline CHEK2 variants (P/LPVs) at our institution.